Update on the Risk of Hepatocellular Carcinoma in Chronic Hepatitis B Virus Infection
- PMID: 21654908
- PMCID: PMC3085101
- DOI: 10.1007/s11901-011-0094-2
Update on the Risk of Hepatocellular Carcinoma in Chronic Hepatitis B Virus Infection
Abstract
Chronic hepatitis B virus infection is an important cause of liver-related morbidity and mortality, with hepatocellular carcinoma being the most life-threatening complication. Because of the highly variable clinical course of the disease, enormous research efforts have been made with the aim of revealing the factors in the natural history that are relevant to hepatocarcinogenesis. These include epidemiological studies of predisposing risk groups, viral studies of mutations within the hepatitis B viral genome, and clinical correlation of these risk factors in predicting the likelihood of development of hepatocellular cancer in susceptible hosts. This update addresses these risks, with emphasis on the latest research relevant to hepatocarcinogenesis.
Similar articles
-
Review article: immunisation against hepatitis B virus infection and the prevention of hepatocellular carcinoma.Aliment Pharmacol Ther. 2021 Jun;53(11):1166-1182. doi: 10.1111/apt.16356. Epub 2021 Apr 28. Aliment Pharmacol Ther. 2021. PMID: 33909923 Review.
-
Hepatitis viruses (other than hepatitis B and C viruses) as causes of hepatocellular carcinoma: an update.J Viral Hepat. 2013 Mar;20(3):149-57. doi: 10.1111/jvh.12043. Epub 2012 Dec 26. J Viral Hepat. 2013. PMID: 23383653 Review.
-
Molecular mechanisms of viral hepatitis induced hepatocellular carcinoma.World J Gastroenterol. 2020 Oct 14;26(38):5759-5783. doi: 10.3748/wjg.v26.i38.5759. World J Gastroenterol. 2020. PMID: 33132633 Free PMC article. Review.
-
Factors predicting occurrence and prognosis of hepatitis-B-virus-related hepatocellular carcinoma.World J Gastroenterol. 2011 Oct 14;17(38):4258-70. doi: 10.3748/wjg.v17.i38.4258. World J Gastroenterol. 2011. PMID: 22090781 Free PMC article. Review.
-
Hepatitis B virus gene mutations and hepatocarcinogenesis.Asian Pac J Cancer Prev. 2013;14(8):4509-13. doi: 10.7314/apjcp.2013.14.8.4509. Asian Pac J Cancer Prev. 2013. PMID: 24083693 Review.
Cited by
-
Transcriptional Profiling and miRNA-Target Network Analysis Identify Potential Biomarkers for Efficacy Evaluation of Fuzheng-Huayu Formula-Treated Hepatitis B Caused Liver Cirrhosis.Int J Mol Sci. 2016 Jun 3;17(6):883. doi: 10.3390/ijms17060883. Int J Mol Sci. 2016. PMID: 27271613 Free PMC article.
-
Evolutionary Changes of Hepatitis B Virus Pre-S Mutations Prior to Development of Hepatocellular Carcinoma.PLoS One. 2015 Sep 30;10(9):e0139478. doi: 10.1371/journal.pone.0139478. eCollection 2015. PLoS One. 2015. PMID: 26421619 Free PMC article.
-
Dynamical Regulation Analysis Identifies Molecular Mechanisms of Fuzheng-Huayu Formula against Hepatitis B-Caused Liver Cirrhosis.Evid Based Complement Alternat Med. 2015;2015:238495. doi: 10.1155/2015/238495. Epub 2015 Jun 28. Evid Based Complement Alternat Med. 2015. PMID: 26221171 Free PMC article.
-
Hepatitis B virus infection is not associated with fatty liver disease: Evidence from a cohort study and functional analysis.Mol Med Rep. 2019 Jan;19(1):320-326. doi: 10.3892/mmr.2018.9619. Epub 2018 Nov 2. Mol Med Rep. 2019. PMID: 30387826 Free PMC article.
-
MiRNA-target network analysis identifies potential biomarkers for Traditional Chinese Medicine (TCM) syndrome development evaluation in hepatitis B caused liver cirrhosis.Sci Rep. 2017 Sep 8;7(1):11054. doi: 10.1038/s41598-017-11351-5. Sci Rep. 2017. PMID: 28887510 Free PMC article.
References
LinkOut - more resources
Full Text Sources